WHO ICTRP trial
EUCTR2004-004528-11-LT · F. Hoffmann-La Roche Ltd
EUCTR2004-004528-11-LT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-004528-11-LT |
|---|---|
| Scientific title | Multicenter, double-blind, randomized, placebo-controlled, dose ranging phase 2 study to investigate efficacy, safety, tolerability and pharmacokinetics of the DPPIV inhibitor RO0730699 in patients with type 2 diabetes - NA |
| Primary sponsor | F. Hoffmann-La Roche Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Estonia;Latvia;Lithuania |
| Conditions | Type 2 diabetes MedDRA version: 7 Level: low Classification code 10012613 |
| Interventions | Product Code: RO0730699 Pharmaceutical Form: Film-coated tablet Other descriptive name: DPP IV (1) Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100 - Pharmaceutical form of the placebo: Film-coated… |
| Registration date | Feb 23, 2005 |
| Target size | 250 |
| Secondary IDs | BM18102 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: